Document is current
Any future updates will be listed below
-
Authors
Kirchner, Sabine
Klotsche, Jens
Liedmann, Ina
Niewerth, Martina
Feldman, Debbie
Dressler, Frank
Foeldvari, Ivan
Foell, Dirk
Haas, Johannes-Peter
Horneff, Gerd
Hospach, Anton
Kallinich, Tilmann
Kuemmerle-Deschner, J. B.
Moenkemoeller, Kirsten
Weller-Heinemann, Frank
Windschall, Daniel
Minden, Kirsten
Sengler, Claudia https://orcid.org/0000-0002-6703-0269
-
Funding
Funding for this research was provided by:
Bundesministerium für Bildung, Wissenschaft und Forschung (FKZ 01ER0812, FKZ 01ER1504A-C)
Deutsches Rheuma-Forschungszentrum Berlin (DRFZ)
- License Information
-
More Information
Article History
Received: 28 November 2022
Accepted: 26 March 2023
First Online: 12 April 2023
Declarations
:
: The study protocol was approved by the ethics committee of Charité—Universitätsmedizin Berlin (reference number EA1/056/10) and conducted in concordance with the Declaration of Helsinki. Parents and patients 8 years of age and older gave their written informed consent for participation.
: Not applicable.
: SK: none; JK: none; IL: none; MN: none; DEF: none, FD: speaker`s fees from Novartis and Pfizer; IF: none, DF: none. JPH: none, GH: grants and personal fees from Abbvie, Chugai, MSD, Novartis, Pfizer, Roche, personal fees from Sobi, GSK, Sanofi, Bayer, AH: none, TK: none, JKD: none, KMm: none, FWH: none, DW: none, KM: received honoraria from Pfizer, Novartis and medac, CS: none.
